|
WO2021062327A1
|
|
Fused pyrimidine compounds, compositions and medicinal applications thereof
|
|
WO2019102494A1
|
|
Heterocyclic compounds as prmt5 inhibitors
|
|
CN109153636A
|
|
Cyclopropyl-amide compound as dual LSD1/HDAC inhibitor
|
|
US2018237453A1
|
|
Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors
|
|
EP3277683A1
|
|
Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer
|
|
US2016207905A1
|
|
Substituted pyrimidine compounds, compositions and medicinal applications thereof
|
|
US2009149485A1
|
|
Pyrimidinediones as tyrosine kinase inhibitors
|
|
US2009171641A1
|
|
Novel homology model of the glycogen synthase kinase 3 alpha and its uses thereof
|
|
US2006106545A1
|
|
Methods of clustering proteins
|
|
US2005114398A1
|
|
Computer-aided visualization and analysis system for signaling and metabolic pathways
|
